An Open Label Individual Patient Study Investigating the Safety and Efficacy of GCAR1 in a Patient with Metastatic Relapsed Alveolar Soft Part Sarcoma
Summary
This study is intended to understand if a new cancer therapy called GCAR1 is safe and effective in treating patients with metastatic cancer.
Eligibility
Eligible ages: 0 to 100
Inclusion criteria:
This study is only open to enroll a single patient who has already been identified.
Participate
Additional information
Contact information
djmahone@ucalgary.ca
Principal investigator:
Mona Shafey
Clinical trial:
Yes
REB-ID:
HREBA.CC-25-0218